Sarepta Therapeutics Statistics
Total Valuation
SRPT has a market cap or net worth of $3.57 billion. The enterprise value is $4.41 billion.
Important Dates
The last earnings date was Tuesday, May 6, 2025, after market close.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SRPT has 98.28 million shares outstanding. The number of shares has increased by 0.83% in one year.
| Current Share Class | 98.28M |
| Shares Outstanding | 98.28M |
| Shares Change (YoY) | +0.83% |
| Shares Change (QoQ) | -10.24% |
| Owned by Insiders (%) | 4.38% |
| Owned by Institutions (%) | 89.08% |
| Float | 93.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 10.80 |
| PS Ratio | 1.56 |
| Forward PS | 1.05 |
| PB Ratio | 3.13 |
| P/TBV Ratio | 3.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 0.23 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.97 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.02, with a Debt / Equity ratio of 1.19.
| Current Ratio | 4.02 |
| Quick Ratio | 2.06 |
| Debt / Equity | 1.19 |
| Debt / EBITDA | 39.65 |
| Debt / FCF | n/a |
| Interest Coverage | -6.26 |
Financial Efficiency
Return on equity (ROE) is -23.61% and return on invested capital (ROIC) is -3.02%.
| Return on Equity (ROE) | -23.61% |
| Return on Assets (ROA) | -2.19% |
| Return on Invested Capital (ROIC) | -3.02% |
| Return on Capital Employed (ROCE) | -4.10% |
| Revenue Per Employee | $1.63M |
| Profits Per Employee | -$181,041 |
| Employee Count | 1,372 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 2.71 |
Taxes
In the past 12 months, SRPT has paid $84.20 million in taxes.
| Income Tax | 84.20M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -72.41% in the last 52 weeks. The beta is 0.84, so SRPT's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | -72.41% |
| 50-Day Moving Average | 68.48 |
| 200-Day Moving Average | 110.17 |
| Relative Strength Index (RSI) | 22.88 |
| Average Volume (20 Days) | 4,349,603 |
Short Selling Information
The latest short interest is 6.70 million, so 6.82% of the outstanding shares have been sold short.
| Short Interest | 6.70M |
| Short Previous Month | 6.62M |
| Short % of Shares Out | 6.82% |
| Short % of Float | 7.14% |
| Short Ratio (days to cover) | 2.43 |
Income Statement
In the last 12 months, SRPT had revenue of $2.23 billion and -$248.39 million in losses. Loss per share was -$2.59.
| Revenue | 2.23B |
| Gross Profit | 449.69M |
| Operating Income | -117.21M |
| Pretax Income | 62.22M |
| Net Income | -248.39M |
| EBITDA | -78.25M |
| EBIT | -117.21M |
| Loss Per Share | -$2.59 |
Full Income StatementBalance Sheet
The company has $522.76 million in cash and $1.36 billion in debt, giving a net cash position of -$833.96 million or -$8.49 per share.
| Cash & Cash Equivalents | 522.76M |
| Total Debt | 1.36B |
| Net Cash | -833.96M |
| Net Cash Per Share | -$8.49 |
| Equity (Book Value) | 1.14B |
| Book Value Per Share | 11.63 |
| Working Capital | 1.83B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$547.15 million and capital expenditures -$148.16 million, giving a free cash flow of -$695.31 million.
| Operating Cash Flow | -547.15M |
| Capital Expenditures | -148.16M |
| Free Cash Flow | -695.31M |
| FCF Per Share | -$7.08 |
Full Cash Flow StatementMargins
Gross margin is 20.14%, with operating and profit margins of -5.25% and -11.12%.
| Gross Margin | 20.14% |
| Operating Margin | -5.25% |
| Pretax Margin | -7.35% |
| Profit Margin | -11.12% |
| EBITDA Margin | -3.50% |
| EBIT Margin | -5.25% |
| FCF Margin | n/a |
Dividends & Yields
SRPT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.83% |
| Shareholder Yield | -0.83% |
| Earnings Yield | -6.95% |
| FCF Yield | -19.45% |
Dividend DetailsAnalyst Forecast
The average price target for SRPT is $131.09, which is 260.43% higher than the current price. The consensus rating is "Buy".
| Price Target | $131.09 |
| Price Target Difference | 260.43% |
| Analyst Consensus | Buy |
| Analyst Count | 23 |
| Revenue Growth Forecast (5Y) | 15.35% |
| EPS Growth Forecast (5Y) | 44.74% |
Stock ForecastsStock Splits
The last stock split was on July 12, 2012. It was a reverse split with a ratio of 0.1666666:1.
| Last Split Date | Jul 12, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.1666666:1 |
Scores
SRPT has an Altman Z-Score of 2.33 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.33 |
| Piotroski F-Score | 1 |